Argentina vs Peru: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Argentina
79.0%
in 2025
Peru
80.0%
in 2025
Argentina rank
121st
Peru rank
118th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Argentina
- Peru
How they compare
Peru currently reports 80.0% against 79.0% in Argentina, a difference of 1.0%.
The two have swapped places 6 times across 18 shared years of data; in 2008 it was Peru ahead.
Argentina ranks 121st and Peru ranks 118th of 194 countries.
Across the 3 decades both report, Argentina averaged higher in 1 and Peru in 2.
Head to head by decade
| Decade | Argentina | Peru | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 4.5% | 4.5% | Peru |
| 2010s | 62.6% | 83.7% | 21.1% | Peru |
| 2020s | 77.0% | 76.7% | 0.3% | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Argentina or Peru?
- Peru, at 80.0% against 79.0% in Argentina as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Argentina and Peru?
- 1.0%, with Peru ahead.
- How many years of comparable data are there for Argentina and Peru?
- 18 years are reported by both, from 2008 to 2025.
- How do Argentina and Peru rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Argentina ranks 121st and Peru ranks 118th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.